BIM.PA Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (16 May 2024 @ 11:35):

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific...

Stats
Today's Volume	150 893
Average Volume	106 939
Market Cap	11.34B
EPS	€1.650 ( 2024-04-09 )
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	31.89
ATR14	€0.0330 (0.03%)

Volume Correlation

Long: -0.11 (neutral)

Short: 0.57 (weak)

Signal:(53.709) Neutral

Biomerieux SA Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Biomerieux SA Correlation - Currency/Commodity

0.58
( weak )

0.43
( neutral )

0.00
( neutral )

0.17
( neutral )

-0.79
( moderate negative )

-0.66
( moderate negative )

Biomerieux SA Financials

Annual	2023
Revenue:	€3.67B
Gross Profit:	€1.89B (51.34 %)
EPS:	€3.03

FY	2023
Revenue:	€3.67B
Gross Profit:	€1.89B (51.34 %)
EPS:	€3.03

FY	2022
Revenue:	€3.59B
Gross Profit:	€1.96B (54.64 %)
EPS:	€3.84

FY	2021
Revenue:	€3.38B
Gross Profit:	€1.96B (58.16 %)
EPS:	€5.09

Financial Reports:

No articles found.

Biomerieux SA Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Biomerieux SA

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.